Animal Health Market, By Animal Type and Companion Animal, By Product , Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics, and Others), Feed Additives , Diagnostics, By Distribution Channel, By End-use, and By Region - Trends, Analysis and Forecast till 2034

Animal Health Market Size was valued at USD 67.5 Billion in 2024 and is expected to reach USD 154.1 Billion by 2034, growing at a CAGR of 9.5%.

The Animal Health Market involves various products and services that are applicable for the well-being and maintenance of food-producing and companion animals. Animal health products are used to cure, prevent, or reduce the risk of diseases, and to continuously monitor the welfare and health of animals. Animal health products consist of feed additives, antimicrobials, antibiotics, diagnostics products, vaccines, growth promoters, and other pharmaceuticals. Numerous products are covered by third market that are used to enhance the productivity of livestock.

The relationship between human and animal populations, as well as the surrounding environment, is especially strong in developing countries, where animals provide transportation, draught power, fuel, clothes, high-quality proteins (meat, eggs, and milk), and a source of revenue. As a result, animal health is an essential component of both sustainable development and livestock production.As changes in livestock production enhance the possibility of novel viruses emerging, growing, and spreading from animals to humans, healthy animals are inextricably linked to healthy people and the environment. In animals, health may be defined as the absence of sickness or the normal functioning of an organism and normal behaviour based on the observation of a given number of individuals that constitute the standard and, hence, health.

As healthy animals are able to generate more offspring, which leads to higher economic activity, furthermore, healthy animals are able to transform food into useful goods like milk and meat more efficiently. In addition, animal health helps people avoid illness transmission. According to one definition, disease is a condition in which normal activities are disrupted or altered at the cellular, tissue, organ, or whole organism levels. In other words, the body's homeostatic functions are disrupted, leading to malfunction.

An animal's typical behaviour involves staying with the herd, having bright eyes, a wet nose without discharge, no wounds, and eating correctly. Signs of a sick animal include being irritable, listless, lame, having a temperature, being separated from the group, not eating or drinking, and so on.Animal can be kept healthy by exercise your pet, give your pet a balanced, nutritious diet. Have a veterinarian examine your pet at least once a year to ensure their health and to discover problems early. Vaccinate your pet against potentially dangerous diseases such as distemper, parvo, panleukopenia and rabies.

Technological advancements in veterinary health care

Advancements in veterinary health care technological is driving the growth of this market, and this is expected to offer future growth opportunities for the market. These advancements include introduction of efficient information management systems, vaccine banks, and animal owner mobile technology. High innovation focus on animal health care has led to rise certain measures that are strengthening growth of the market prospects. For instance, the Innovative Medicines Initiative (IMI) is a public-private partnership to promote collaborative research in order to drive veterinary pharmaceuticals innovations in Europe.

Rising number of government initiatives

Growing number of government initiatives to support animal health products is accelerated to the overall market. As per the data published by UN Department of Economic and Social Affairs, the global population is around 7.3 billion and it is projected to reach nearly 9.7 billion by 2050, of which 795 million people are malnourished, as per the projection of the International Fund for Agricultural Development (IFAD).

However, lack of standardization and growing influx of counterfeit drugs is expected to limit growth of the target market.

Animal health market is segmented based on animal type, product, distribution channel, end-user, and region.

On the basis of animal type, the global animal health market is segmented into production animal (poultry, swine, cattle, sheep & goats, and fish) and companion animal (dogs, cats, horses, and others). On the basis of product, the global market is classified into vaccines (live attenuated vaccines, dna vaccines, recombinant vaccines, inactivated vaccines, and others), pharmaceuticals (parasiticides, anti-infectives, anti-inflammatory, analgesics, and others), feed additives (nutritional and medicinal), diagnostics (instruments and consumables), and others) Based on distribution channel, the global market is classified into Retail, E-commerce, and veterinary hospitals & clinics. Based on end-user, the global market is classified into reference laboratories, point-of-care testing/in-house testing, veterinary hospitals & clinics, and others

Regional Insights:

On region the global animal health market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to register largest revenue share in the he animal health market over the foreseeable future. This can be attributed due to increasing government’s initiatives to promote and improve animal health in the region. Additionally, increasing number of pet owners, the prevalence of zoonotic diseases, and technological advancements are factors boosting market growth in the region.

Animal Health Market Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 – 2034
Market Segmentation	By Animal Type- Production Animal (Poultry, Swine, Cattle, Sheep & Goats, and Fish) and Companion Animal (Dogs, Cats, Horses, and Others) By Product– Vaccines (Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, and Others), Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics, and Others), Feed Additives (Nutritional, Medicinal, Diagnostics, Instruments, and Consumables), and Others) By Distribution Channel– Retail, E-commerce, and Veterinary Hospitals & Clinics By End-user– Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the global animal health market report based on animal type, product, distribution channel, end-user, and region.

Animal Health Market, By Product:

• Production Animal

• Poultry
• Swine
• Cattle
• Sheep & Goats
• Fish

• Companion Animal

• Dogs
• Cats
• Horses
• Others

Animal Health Market, By Application:

• Vaccines

• Live Attenuated Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• Others

• Pharmaceuticals

• Parasiticides
• Anti-infectives
• Anti-inflammatory
• Analgesics
• Others

• Feed Additives

• Nutritional
• Medicinal

• Diagnostics

• Instruments
• Consumables

• Others

Animal Health Market, By Distribution Channel:

• Retail
• E-commerce
• Veterinary Hospitals & Clinics

Animal Health Market, By End-user:

• Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

Animal Health Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the global animal health market includes Bayer AG, H. Boehringer Sohn AG & Co. KG, Dechra Pharmaceuticals Plc, Cadila Healthcare Ltd., Elanco Animal Health Inc., Heska Corp., Norbrook Laboratories Ltd., Merck & Co. Inc., Virbac SA, and Zoetis Inc. The enumerated growth by the animal health market is a result of wide-range regional expansion strategies, collaborative research initiatives, and mergers and acquisitions undertaken by major market players. In December 2016, Bayer AG signed an agreement with Boehringer Ingelheim Vetmedica, Inc. (BIVI) to acquire BIVI’s bovine endectocide and Cydectin ovine products. This acquisition was aimed to drive Bayer’s product portfolio.

• In June 2024, Animal health monitoring solution launched PiMS partnership integration. Mella Pet Care, a health monitoring solution provider for veterinarians and pet owners, has announced a key partnership integration with practice management system (PiMS) provider Vetspire. Using their existing workflows, veterinarians can now integrate Vetspire and other PiMS with the Mella Pet Care desktop app to instantly collect vital signs from Mella devices.
• In May 2024, The World Organisation for Animal Health (WOAH) has granted official recognition for six priority diseases, a move that supports national livestock economies and facilitates regional and international trade. In 2024, five countries, including Azerbaijan, Czech Republic, Norway, Egypt, and Liechtenstein, achieved these statuses. These achievements demonstrate progress in combating highly contagious livestock diseases, recognizing effective disease control, prevention, and early detection measures, and enhancing access to regional and international markets.
• In August 2023, India to get $25 million grant for strengthening animal health system. India is among the very few countries which has got funding for safeguarding animal health. India will receive $25 million from the G20 Pandemic Fund to strengthen the country's animal health system. The fund, established under Indonesia's G20 Presidency, is aimed at low-to-middle-income countries, financing efforts such as surveillance, research, and improved access to vaccines, among other measures.

• Bayer AG
• H. Boehringer Sohn AG & Co. KG
• Cadila Healthcare Ltd.
• Dechra Pharmaceuticals Plc
• Elanco Animal Health Inc.
• Heska Corp.
• Merck & Co. Inc.
• Norbrook Laboratories Ltd.
• Virbac SA
• Zoetis Inc